Poll: 59 percent of voters have little or no trust in Trump on health care

President Trump wants to make the Republican Party the "party of health care." But a new poll suggests he has a lot of work to do.
In a Politico/Morning Consult poll released on Wednesday, 59 percent of registered voters said they have little or no trust in Trump to protect the U.S. health-care system or make improvements to it. This includes 13 percent who said they have "not much" trust, and 46 percent said they have no trust at all. Another 18 percent said they have "some" trust in Trump, while 22 percent said they have "a lot" of trust.
This isn't just a problem with Trump, though. When asked who they trust more to handle health care, 45 percent of voters said Democrats in Congress compared to 35 percent who said Republicans in Congress. And 53 percent said they have either "a lot" or "some" trust in Democrats on the issue, while 41 percent said the same for Republicans.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Trump began a new health-care push last week when it was announced that his Justice Department was asking courts to strike down all of ObamaCare. Trump subsequently said Republicans would try again to come up with a replacement for the health-care law, although he said on Monday that a vote on any replacement would be put off until 2021, all but ensuring health care will become a key issue in the 2020 presidential election.
Politico/Morning Consult's survey was conducted by speaking to 1,945 registered voters from March 29 - April 1. The margin of error is 2 percentage points. Read the full results at Politico.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brendan worked as a culture writer at The Week from 2018 to 2023, covering the entertainment industry, including film reviews, television recaps, awards season, the box office, major movie franchises and Hollywood gossip. He has written about film and television for outlets including Bloody Disgusting, Showbiz Cheat Sheet, Heavy and The Celebrity Cafe.
-
Property turns a corner
The outlook for the housing market is starting to look up as rates fall and confidence returns, according to Strutt & Parker.
By Sponsored Content Published
-
What happens when a pope dies?
In The Spotlight Vatican protocol on a pontiff's death is steeped in tradition and ritual
By Chas Newkey-Burden, The Week UK Published
-
Ukrainian election: who could replace Zelenskyy?
The Explainer Donald Trump's 'dictator' jibe raises pressure on Ukraine to the polls while the country is under martial law
By Sorcha Bradley, The Week UK Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published